Related Experiment Video
Updated: Jul 13, 2026
06:48
Rapid Formation and Testing of Self-expanding NiTi Frames with a Small Form Factor Suitable for Minimally Invasive Implants
Published on: March 7, 2025
Reduced foreign body response at nitric oxide-releasing subcutaneous implants
Evan M Hetrick1, Heather L Prichard, Bruce Klitzman
1Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Biomaterials
|August 8, 2007
Summary
Nitric oxide (NO)-releasing implants significantly reduce scar tissue formation and inflammation. These NO-releasing devices also promote blood vessel growth, improving integration with surrounding tissues.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Medical Device Development
Background:
- Subcutaneous implants often elicit foreign body responses, leading to scar tissue formation and reduced device efficacy.
- Controlling the local biological response to implanted materials is crucial for improving medical device performance.
- Nitric oxide (NO) is a signaling molecule with known anti-inflammatory and vasodilatory properties.
Purpose of the Study:
- To evaluate the host tissue response to subcutaneous implants engineered to release nitric oxide (NO).
- To assess the impact of NO release on foreign body capsule formation, inflammation, and vascularization.
- To determine the potential of NO-releasing implants for enhanced biocompatibility and integration.
Main Methods:
- Fabrication of silicone elastomer implants coated with diazeniumdiolate-modified xerogel polymers capable of NO release.
- Comparison of NO-releasing implants against uncoated silicone elastomer and non-NO-releasing xerogel-coated controls.
- Histological and immunohistochemical analysis (CD-31 staining) of host tissue response at 1, 3, and 6 weeks post-implantation.
Main Results:
- NO-releasing implants demonstrated a >50% reduction in collagen capsule thickness compared to controls after 3 weeks.
- A >30% reduction in chronic inflammatory response was observed at NO-releasing implants after 3 and 6 weeks.
- Approximately 77% more blood vessels were found near NO-releasing implants after 1 week compared to controls.
Conclusions:
- Conferring NO release to subcutaneous implants effectively mitigates foreign body responses, including scar tissue formation and inflammation.
- NO-releasing implants promote neovascularization, suggesting improved integration into host tissues.
- These findings indicate that NO-releasing implants hold promise for enhancing the performance and longevity of various indwelling medical devices.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...